ENvue Medical, Inc. (FEED)
Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 20266 patents granted to the 3 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to ENvue Medical, Inc.’s names, not what it holds today.
4 published
0 published
0 published
| Granted | Patent | Title | Field | Owner as printed |
|---|---|---|---|---|
| Sep 9, 2025 | 12,409,105 | Insertion device positioning guidance system and method | Medical technology | ENVUE MEDICAL HOLDINGS, CORP. |
| Sep 2, 2025 | 12,402,953 | Insertion device positioning guidance system and method | Medical technology | ENVUE MEDICAL HOLDINGS, CORP. |
| Jun 10, 2025 | 12,324,632 | Insertion device positioning guidance system and method | Medical technology | ENVUE MEDICAL HOLDINGS, CORP. |
| Mar 7, 2017 | 9,585,977 | System and method for surface acoustic wave treatment of skin | Medical technology | NANOVIBRONIX, INC |
| May 12, 2015 | 9,028,748 | System and method for surface acoustic wave treatment of medical devices | Medical technology | NANOVIBRONIX, INC |
| Jul 1, 2008 | 7,393,501 | Method, apparatus and system for treating biofilms associated with catheters | Medical technology | NANOVIBRONIX, INC |
| Published | Application | Title | Field | Owner as printed |
|---|---|---|---|---|
| Jul 4, 2024 | 2024/0216718 | PORTABLE ULTRASOUND SYSTEM AND METHODS OF TREATING FACIAL SKIN BY APPLICATION OF SURFACE ACOUSTIC WAVES | Medical technology | NANOVIBRONIX, INC. |
| Nov 30, 2023 | 2023/0381352 | SYSTEM, DEVICE, AND METHOD FOR MITIGATING BACTERIAL BIOFILMS ASSOCIATED WITH INDWELLING MEDICAL DEVICES | Medical technology | NANOVIBRONIX, INC. |
| Sep 14, 2023 | 2023/0285038 | INJECTION NEEDLE ASSEMBLY | Medical technology | NANOVIBRONIX, INC. |
| Mar 24, 2022 | 2022/0087948 | TRANSDERMAL PATCH OF A PORTABLE ULTRASOUND-GENERATING SYSTEM FOR IMPROVED DELIVERY OF THERAPEUTIC AGENTS AND ASSOCIATED METHODS OF TREATMENT | Pharmaceuticals | NANOVIBRONIX, INC. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.